These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1. Williams AC, Browne SJ, Manning AM, Daffada P, Collard TJ, Paraskeva C. Oncogene; 1994 May; 9(5):1479-85. PubMed ID: 8152811 [Abstract] [Full Text] [Related]
9. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta. Manning AM, Williams AC, Game SM, Paraskeva C. Oncogene; 1991 Aug; 6(8):1471-6. PubMed ID: 1886718 [Abstract] [Full Text] [Related]
11. Characterization of the human polymeric immunoglobulin receptor (PIGR) 3'UTR and differential expression of PIGR mRNA during colon tumorigenesis. Traicoff JL, De Marchis L, Ginsburg BL, Zamora RE, Khattar NH, Blanch VJ, Plummer S, Bargo SA, Templeton DJ, Casey G, Kaetzel CS. J Biomed Sci; 2003 Aug; 10(6 Pt 2):792-804. PubMed ID: 14631119 [Abstract] [Full Text] [Related]
12. Mutant p53 is not fully dominant over endogenous wild type p53 in a colorectal adenoma cell line as demonstrated by induction of MDM2 protein and retention of a p53 dependent G1 arrest after gamma irradiation. Williams AC, Miller JC, Collard TJ, Bracey TS, Cosulich S, Paraskeva C. Oncogene; 1995 Jul 06; 11(1):141-9. PubMed ID: 7624121 [Abstract] [Full Text] [Related]
13. Both transforming growth factor-beta and substrate release are inducers of apoptosis in a human colon adenoma cell line. Wang CY, Eshleman JR, Willson JK, Markowitz S. Cancer Res; 1995 Nov 01; 55(21):5101-5. PubMed ID: 7585558 [Abstract] [Full Text] [Related]
14. Oncogenes, suppressor genes, and allele losses in colon cancer. Yaremko ML, Wasylyshyn ML, Westbrook CA, Michelassi F. Adv Surg; 1993 Nov 01; 26():323-32. PubMed ID: 8380308 [No Abstract] [Full Text] [Related]
15. Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect. Hsu S, Huang F, Friedman E. J Cell Physiol; 1995 Nov 01; 165(2):239-45. PubMed ID: 7593201 [Abstract] [Full Text] [Related]
16. Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas. Fazeli A, Steen RG, Dickinson SL, Bautista D, Dietrich WF, Bronson RT, Bresalier RS, Lander ES, Costa J, Weinberg RA. Proc Natl Acad Sci U S A; 1997 Sep 16; 94(19):10199-204. PubMed ID: 9294187 [Abstract] [Full Text] [Related]
17. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells. Ye SC, Foster JM, Li W, Liang J, Zborowska E, Venkateswarlu S, Gong J, Brattain MG, Willson JK. Cancer Res; 1999 Sep 15; 59(18):4725-31. PubMed ID: 10493532 [Abstract] [Full Text] [Related]
18. C8orf4 is a transforming growth factor B induced transcript downregulated in metastatic colon cancer. Friedman JB, Brunschwig EB, Platzer P, Wilson K, Markowitz SD. Int J Cancer; 2004 Aug 10; 111(1):72-5. PubMed ID: 15185345 [Abstract] [Full Text] [Related]
20. A frequent alteration of p53 gene in carcinoma in adenoma of colon. Ohue M, Tomita N, Monden T, Fujita M, Fukunaga M, Takami K, Yana I, Ohnishi T, Enomoto T, Inoue M. Cancer Res; 1994 Sep 01; 54(17):4798-804. PubMed ID: 8062281 [Abstract] [Full Text] [Related] Page: [Next] [New Search]